Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bio Protocol (BIO) vs Covalent X Token (CXT) Price & Performance

Bio ProtocolTrade
Covalent X TokenTrade

Price performance (Past 24H)

Key statistics

Bio Protocol vs Covalent X Token — how do they compare? Bio Protocol trades at Rp437.56 (market cap Rp995,56M, Rp174,03M 24h volume), while Covalent X Token trades at Rp42.98 (market cap Rp41,82M, Rp2,61M 24h volume). The key difference: Bio Protocol is far larger — about 23.8× Covalent X Token's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 969,3M / 1B CXT (97%) for Covalent X Token. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Covalent X Token for 4 Days on average.

BIOCXT
Market Cap
Rp995,56MRp41,82M
Volume (24h)
Rp174,03MRp2,61M
Circulating Supply
2,3B / 3,3B BIO (69%)969,3M / 1B CXT (97%)
Typical Hold Time
17 Days4 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bio Protocol

Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.

Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.

Covalent X Token

CXT is trading at Rp43.04 with a market cap of Rp41.71M, showing 97% circulating supply distribution. The token demonstrates moderate network activity with a 4-day average hold time. Recent trading patterns indicate stable price action within a narrow range, suggesting consolidation phase. No major protocol upgrades or ecosystem developments have been reported recently, maintaining baseline network functionality.

Outlook remains neutral with limited near-term catalysts. Key opportunity lies in potential ecosystem expansion, while risks include low liquidity and typical crypto volatility. Investors should monitor for protocol updates and exchange listing developments that could impact token utility and valuation.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BIO
39% Buy61% Sell
Avg holding period · 17 Days
CXT
100% Buy0% Sell
Avg holding period · 4 Days

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO

About Covalent X Token

CXT is the utility and governance token of the Covalent Network, which safeguards Ethereum’s historical data. It is used for staking and enables holders to participate in decentralized governance. The network enhances data availability for developers building on the Ethereum ecosystem.

Read more on CXT